Show notes
In episode 548, James and Mike invite Betsy Thomas back to the podcast to talk about whether or not measuring lipoprotein(a) or apolipoprotein B improves cardiovascular risk prediction in a meaningful way over and above using standard risk factors. Many guidelines are now recommending we should do these measurements but is this an evidence-based recommendation? Give us 30 minutes of your time and you’ll know the answer.
Show Notes
Less is More Unless it’s Sleep or Toilet Paper: Non-traditional lipoproteins for cardiovascular risk Tools for Practice
